Galderma Group AG (XSWX:GALD) Buildings And Improvements : CHF66 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Buildings And Improvements?

Galderma Group AG's quarterly buildings and improvements declined from Dec. 2023 (CHF74 Mil) to Jun. 2024 (CHF70 Mil) and declined from Jun. 2024 (CHF70 Mil) to Dec. 2024 (CHF66 Mil).

Galderma Group AG's annual buildings and improvements increased from . 20 (CHF0 Mil) to Dec. 2023 (CHF74 Mil) but then declined from Dec. 2023 (CHF74 Mil) to Dec. 2024 (CHF66 Mil).

Galderma Group AG Buildings And Improvements Historical Data

The historical data trend for Galderma Group AG's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Buildings And Improvements Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Buildings And Improvements

74.37

65.98

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Buildings And Improvements	-	74.37	69.72	65.98

Galderma Group AG Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

GALDY:USA GDERF:USA GALDz:UK PY3:Germany

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines